JULIE DREADIN: Open Payments
NPI 1225109515 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$186 in 8 payments from 5 companies in 2025. Trend: 2023 $142 · 2024 $107 · 2025 $186
Food & beverage: $186
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 3 | $64 |
| Regeneron Healthcare Solutions, Inc. | 2 | $51 |
| Daiichi Sankyo Inc. | 1 | $28 |
| Astellas Pharma US Inc | 1 | $22 |
| Gilead Sciences, Inc. | 1 | $20 |
Products named: LIBTAYO, MONJUVI, Enhertu, JAKAFI, Xtandi, Trodelvy.
Industry payments across TX — which companies pay providers there.
